îæ€çŽ¢
îæ€çŽ¢
î
Celularity Inc
CELUîãŠã©ãããªã¹ãã«è¿œå
1.150USD
-0.030-2.54%
çµå€Â 09-23 16:00ïŒETïŒ
33.29Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Celularity IncïŒCELUïŒç®æšæ ªäŸ¡ïŒèŠéã
ç®æšæ ªäŸ¡
6.000USD+714.44%
CELU ã¢ããªã¹ãæšå¥šãã¬ã³ã
ä»æãCELUã¯0件ã®ãè²·ããã0件ã®ãäžç«ïŒããŒã«ãïŒãã0件ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããCELUã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯6.000ã§ãã
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
CELU åæ¥è æ¯èŒã¢ããªã¹ãè©äŸ¡
æŽæ°æå»: Sep 23, 2026äŒç€Ÿå
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ã¢ããªã¹ã
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
FY2025Q2
FY2025Q3
FY2025Q4
äºæž¬å€
-0.75
-1.50
-1.50
å®çžŸå€
-1.02
-0.88
-0.86
ãµãã©ã€ãº
-36.15%
+41.61%
+42.73%
ãããã質å
Celularity Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãCelularity Inc ã®ç®æšæ ªäŸ¡ã USD 6.00 ãšäºæ³ããæé«äºæ³ã¯ USD 6.00ãæäœäºæ³ã¯ USD 6.00 ãšäºæ³ããŠããŸãã